Wordt geladen...
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
Abstract Background Bladder cancers have been characterized as a tumor group in which the immunological response is relatively well preserved. Programmed death ligand 1 (PD-L1, B7-H1, CD274) has been shown to be expressed in several malignancies, including bladder cancer. However, the clinicopatholo...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BMC
2018-11-01
|
Reeks: | BMC Urology |
Onderwerpen: | |
Online toegang: | http://link.springer.com/article/10.1186/s12894-018-0414-8 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|